Table 2.
Quantitative outcomes of ATL patients at diagnosis and sanitary evacuation status.
| Characteristic | Unit | All N = 41 | ATL subtypes according to Shimoyama's |
p | |||
|---|---|---|---|---|---|---|---|
| Acute N = 23 | Lymphoma N = 14 | Chronic N = 1 | PCT-ATL N = 1 | ||||
| Age at diagnosis | Median (IQR) years | 54.5 (17–88) | 54 (30–88) | 61 (17–78) | 59 | 42 | 0.637 |
| Leukocytes | G/L (range) | 12 (1.6–120) | 44.4 (3.9–120) | 7 (1.6–15) | 6.8 | 2.4 | 0.0002 |
| Abnormal lymphocytes | N/mm 3 (% of Leukocytes) | – | 35,000 (48.9%) | 0 | 0 | NA | 0.0001 |
| Creatinine | μmol/L (range) | 76 (42–403) | 89 (44–403) | 73.5 (42–137) | 55 | 61 | 0.2844 |
| LDH | UI/L (range) | 790 (221–12,739) | 820 (221–3351) | 703.5 (286–12739) | 367 | 683 | 0.675 |
| Calcemia | mmol/L (range) | 3.1 (2.09–6.5) | 3.66 (2.3–6.5) | 2.5 (2.09–4.8) | 2.51 | 2.48 | 0.0155 |
| Hypercalcemia at diagnosis | % | 55% | 69.5% | 42.8% | 0 | 0 | 0.0155 |
| Time interval from diagnosis to initiation of treatment | Median (IQR) days | 13 (7–29) | 12 (7–25) | 15.5 (7–30) | 0 | 0 | 0.8 |
| Median survival time from the initiation of treatment | Median (IQR) days | 107 (51–257) | 92 (51–259) | 108 (51–124) | 0 | 0 | 0.42 |
Quantitative outcomes and sanitary evacuation of 41 ATL patients diagnosed between 2009 and 2019.
Abbreviations: PCT-ATL: Primary Cutaneous Tumor-Adult T-cell Leukemia; IQR: Interquartile; LDH: Lactate Dehydrogenase.